Status:
COMPLETED
A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough
Lead Sponsor:
Xention Ltd
Collaborating Sponsors:
Ario Pharma Ltd
Conditions:
Chronic Idiopathic Cough
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the effectiveness of XEN-D0501 over placebo in reducing the daytime cough frequency in patients with chronic idiopathic cough. The effectiveness of XEN-D0501...
Eligibility Criteria
Inclusion
- Male/female subjects aged 18 or over with chronic idiopathic cough
Exclusion
- Clinically significant medical history
- Abnormal laboratory results, ECGs or vital signs
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT02233699
Start Date
July 1 2014
End Date
May 1 2015
Last Update
July 15 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Belfast City Hospital
Belfast, Ireland, BT9 7AB
2
University Hospital of South Manchester
Manchester, United Kingdom, M23 9LT